SCHEMBL6926923

SCHEMBL6926923

O=C1NC(=O)C(=Cc2cccc(NC(=O)c3ccc(NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)cc3)c2)S1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 4/20 0.54
PIM2 Q9P1W9 4/20 0.54
PTPN1 P18031 5/20 0.50
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HDAC4 P56524 4/20 0.47
HDAC1 Q13547 3/20 0.47
HDAC8 Q9BY41 3/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
TTR P02766 1/20 0.45
CISD1 Q9NZ45 1/20 0.45
SCN9A Q15858 1/20 0.45
NR1H4 Q96RI1 1/20 0.43
HDAC3 O15379 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926921 1.00 PIM1 (0.54) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6927642 0.89 PSD (0.54) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6927645 0.89 PSD (0.54) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6929933 0.87 KMT2A (0.51) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6929936 0.87 KMT2A (0.51) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6927082 0.87 NAMPT (0.51) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6927181 0.87 MEN1 (0.52) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6927087 0.87 NAMPT (0.51) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6927180 0.87 MEN1 (0.52) PIM1PIM2PTPN1LMNASMN1; SMN2
SCHEMBL6926263 0.82 PIM1 (0.67) PIM1PIM2SMN1; SMN2HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518268-B1 Telomerase inhibitors and methods of their use GERON CORPORATION 2003-02-11 US disclosed
WO-2001002377-A9 TELOMERASE INHIBITORS AND METHODS OF THEIR USE GERON CORP (US) 2001-10-11 WO disclosed
EP-1109796-A1 TELOMERASE INHIBITORS AND METHODS OF THEIR USE Geron Corporation (US) 2001-06-27 EP disclosed
WO-2001002377-A1 TELOMERASE INHIBITORS AND METHODS OF THEIR USE GERON CORPORATION (US) 2001-01-11 WO disclosed